Table 2.
Clinical outcomes in the active and sham ts-DCS groups.
| Outcome | Active ts-DCS (n = 19) | Sham ts-DCS (n = 14) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Post hoc (p value) | Post hoc (p value) | |||||||||||
| T0 | T1 | T2 | Time | T1 vs. T0 | T2 vs. T0 | T0 | T1 | T2 | Time | T1 vs. T0 | T2 vs. T0 | |
| NPSI | 37.4 ± 21.4 | 25.3 ± 13.8 | 21.0 ± 14.4 | F(2,17) 5.175; p = 0.013 | 0.023 | 0.008 | 40.0 ± 17.9 | 34.3 ± 10.2 | 33.7 ± 13.2 | F(2,12) 1.434; p = 0.277 | n.s. | n.s. |
| FSS | 41.8 ± 13.4 | 41.1 ± 14.1 | 37.6 ± 11.5 | F(2,17) 1.177; p = 0.331 | n.s. | n.s. | 49.0 ± 12.1 | 47.2 ± 11.0 | 48.5 ± 13.0 | F(2,12) 0.330; p = 0.725 | n.s. | n.s. |
| AS | 1.75 ± 0.8 | 1.8 ± 0.8 | 1.8 ± 1.1 | F(2,17) 0.643; p = 0.537 | n.s. | n.s. | 1.2 ± 0.9 | 1.5 ± 1.2 | 1.2 ± 0.6 | F(2,12) 1.200; p = 0.335 | n.s. | n.s. |
Data are reported as mean ± SD. ts-DCS, transcutaneous spinal direct current stimulation; NPSI, Neuropathic Pain Symptoms Inventory; FSS, Fatigue Severity Scale; AS, Ashworth Scale; n.s., not significant (p value > 0.05).